Foreign-invested pharmaceutical firms seeking strategic alliance with Daewoong

Published: 2008-07-10 06:02:00

Updated: 2008-07-10 06:02:00

Some multinational companies stationed in Korea are eager to establish strategic alliances with Daewoong Pharm as Daewoong holds strong sales and marketing force in the domestic pharmaceutical market, despite Daewoong’s recent severance with Menthlatum Korea over the latter’s several products.

...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK